ArticleInfectious disease reports2022

Efficacy and Safety of the Treatment of Chronic Hepatitis C with Sofosbuvir/Ledipasvir in Children Aged 5 to 10 Years with Comorbidities-A Brief Report.

Maria Pokorska-Śpiewak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.